1.800GBp0.00%Mkt Cap: 7.87M GBpP/E: —Last update: 2026-05-13
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …
Industry Peers
Health Information Services6.05BSEKP/E 27.0
1.61BSEKP/E 24.1
444.31MEURP/E 27.5
76.11MEURP/E 13.0
64.81MNOK—
59.64MEUR—
52.52MSEK—
42.95MEURP/E 13.6
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-0.20
PEG—
P/B-8.12
P/S2.38
EV/EBITDA—
EV/Revenue2.26
EPS (TTM)-0.03
EPS (Forward)-0.09
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF-17.90M GBp
CapEx (TTM)—
Net Debt/EBITDA—
Net Debt-400.00K GBp
Technical
SMA 502.150 (-16.3%)
SMA 2005.456 (-67.0%)
Beta1.82
S&P 52W Chg24.23%
Avg Vol (30d)1.13M
Avg Vol (10d)193.81K
Technical Indicators
RSI (14)13.5
MACD-0.1731
MACD Signal-0.2182
MACD Hist.+0.0451
BB Upper2.010 GBp
BB Middle1.865 GBp
BB Lower1.720 GBp
BB Width15.60%
ATR (14)0.3041 GBp
Vol Ratio (20d)0.03x
52W Range
1.6001% of range15.50
52W High15.50 GBp
52W Low1.600 GBp
Profitability
Gross Margin40.00%
EBITDA Margin0.00%
Profit Margin-680.00%
Oper. Margin-437.50%
ROE291.43%
ROA-334.43%
Revenue Growth2.80%
Earnings Growth—
Balance Sheet
Debt/Equity-1.19
Current Ratio1.57
Quick Ratio1.39
Book Value/Sh-0.0022 GBp
Cash/Share0.0140 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.437.02M
Float363.95M
Insiders26.69%
Institutions57.69%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap7.87M GBp
Enterprise Value7.47M GBp
Revenue (TTM)3.30M GBp
Gross Profit1.20M GBp
Net Income (TTM)-20.40M GBp
Revenue/Share0.0090 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees46
Last Price1.800 GBp
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN—